ENvue Medical Inc. (FEED) Live Share Price, Invest From India

ENvue Medical Inc. Stock Performance

as on August 1, 2026 at 2:15 pm IST

Day's Low
Day's High
$0.29
Day's Price Range
$0.32
$0.32
8.11%
Downside
1.39%
Upside
52 Week's Low
52 Week's High
52-Week Price Range
$0.32
100.00%
Downside
-100.00%
Upside

ENvue Medical Inc. share price movements today

Previous Close: $0.32
Open: $0.31
Volume: 947.3K
Day's Low - High: $0.29 - $0.32

ENvue Medical Inc. Historical Returns

1 Month Return: -39.31 %
3 Month Return: -73.48 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

ENvue Medical Inc. Stock Fundamentals & Key Indicators

Check ENvue Medical Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.9M

EPS (TTM)

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-59.49%

ENvue Medical Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of ENvue Medical Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
ENvue Medical Inc.	NA	$1.9M	NA	NA	0.00%	NA
Stryker Corporation	BUY	$133.4B	20.6%	40.8	13.21%	0.98%
Edwards Lifesciences Corp	BUY	$49.6B	-24.02%	51.23	15.43%	NA
Medtronic plc	BUY	$111.2B	-34.95%	23.48	13.20%	3.2399999999999998%
Abbott Laboratories	BUY	$182.7B	-12.59%	34.97	11.65%	2.3%

See all

Indian Investors' Interest in ENvue Medical Inc. Stock

Search interest for ENvue Medical Inc. Stock has decreased by -65% in the last 30 days, reflecting a downward trend in search activity.

Time period: July 3, 2026 to August 2, 2026

Change:-65% versus previous 30 day period

ENvue Medical Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	1	0	0	0	0	1	0	0	0	0
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	0	0	0	0	-1	-1	-3	-2	-3	-3
EBITDA	0	0	0	0	-1	-2	-3	0	-6	-3
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	-	-	0	0	0	0	0
Income Before Tax	0	0	0	0	-1	-2	-3	0	-13	-3
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	0	0	0	0	-1	-2	0	0	-12	-3
Net Profit Margin	-69.07%	-63.84%	-84.21%	-265.43%	-322.30%	-243.41%	-31.58%	83.10%	-4119.23%	-585.30%

ENvue Medical Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	0	0	0	0	0	1	0	2	2	2
Gross Profit	0	0	0	0	0	0	0	1	1	0
Operating Income	-2	-3	-4	-5	-4	-5	-5	-3	-3	-11
EBITDA	-2	-3	-4	-5	-4	-14	-5	-3	-3	-17
Interest Expense	0	1	-	0	0	-	0	0	0	0
Depreciation	-	-	-	-	-	0	0	0	0	0
Income Before Tax	-2	-4	-4	-5	-4	-14	-5	-3	-3	-18
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-2	-5	-4	-5	-4	-14	-5	-3	-3	-18
Net Profit Margin	-1236.24%	-2429.29%	-1306.29%	-1093.21%	-694.22%	-842.60%	-724.47%	-162.55%	-144.84%	-712.30%

ENvue Medical Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	0	0	-1	-2	0	0	-12	-21
Operating Cash Flow	0	0	0	-1	-3	-1	-2	-4
Investing Cash Flow	0	-	-	0	0	0	0	0
Financing Cash Flow	-	0	-	1	6	4	0	2
Change in Cash	0	0	0	0	3	2	-2	-1

ENvue Medical Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-5	-4	-5	-4	-14	-5	-3	-3	-18
Operating Cash Flow	-2	-3	-3	-3	-4	-7	-3	-2	-9
Investing Cash Flow	-	0	-	0	0	0	0	0	0
Financing Cash Flow	6	0	4	9	4	2	4	0	12
Change in Cash	4	-3	0	6	0	-5	0	-2	3

Global Institutional Holdings in ENvue Medical Inc.

Funds	Holdings
Tower Research Capital LLC	0.05%
FMR Inc	0.01%
Vanguard Fiduciary Trust Co	0%
UBS Group AG	0%
Citigroup Inc	0%

See all

Insights on ENvue Medical Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -12.85M → -3.82M (in $), with an average increase of 236.3% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 312.0K → 653.0K (in $), with an average increase of 52.2% per quarter
NO EFFECT
Against Peers
In the last 3 years, Stryker Corporation has given 7.1% return, outperforming this stock by 107.0%
NO EFFECT
Against Peers
In the last 1 year, Edwards Lifesciences Corp has given 8.5% return, outperforming this stock by 104.7%
NEGATIVE IMPACT
Price Dip
In the last 7 days, FEED stock has moved down by -17.4%

About ENvue Medical Inc.

ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at-home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use. The company also offers PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures. In addition, it provides WoundShield, a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Europe, Australia, Israel, New Zealand, and internationally. The company was formerly known as NanoVibronix, Inc. and changed its name to ENvue Medical, Inc. in December 2025. The company was incorporated in 2003 and is based in Tyler, Texas.

Organisation	ENvue Medical Inc.
Headquarters	969 Pruitt Ave, Tyler, TX, United States, 77569
Industry	Medical Devices
CEO	Dr. Doron Robert Besser M.D.
E-voting on shares	Click here to vote

Key Management of ENvue Medical Inc.

Name	Title
Dr. Doron Robert Besser M.D.	CEO, President & Director
Ms. Rita Silberberg	Executive VP of Finance, Chief Accounting Officer & Corporate Secretary
Ms. Lindsey Harrison	Vice President of Sales

FAQs

What is ENvue Medical Inc. share price today?

ENvue Medical Inc. share price today is $0.32 as on August 1, 2026 at 8:45 am IST at the close of the market. ENvue Medical Inc. share today touched a day high of $0.32 and a low of $0.29.

What is the 52 week high and 52 week low for ENvue Medical Inc. share?

ENvue Medical Inc. share touched a 52 week high of $0.00 on January 1, 1970 and a 52 week low of $0.00 on January 1, 1970. ENvue Medical Inc. stock price today i.e. August 1, 2026 at 8:45 am IST is closed at $0.32,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.

What is ENvue Medical Inc.'s market capitalisation today?

ENvue Medical Inc. market capitalisation is $0.00T as on August 1, 2026 at 8:45 am IST.

How to invest in ENvue Medical Inc. Stock (FEED) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for ENvue Medical Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in ENvue Medical Inc. Shares that will get you 4.7529 shares as per ENvue Medical Inc. share price of $0.32 per share as on August 1, 2026 at 8:45 am IST.

What is the minimum amount required to buy ENvue Medical Inc. Stock (FEED) from India?

Indian investors can start investing in ENvue Medical Inc. (FEED) shares with as little as ₹95.39 or $1 (as of August 2, 2026 at 2:39 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹953.90 in ENvue Medical Inc. stock (as per the Rupee-Dollar exchange rate as on August 2, 2026 at 2:39 pm IST). Based on ENvue Medical Inc. share’s latest price of $0.32 as on August 1, 2026 at 8:45 am IST, you will get 31.6857 shares of ENvue Medical Inc.. Learn more about fractional shares .